Literature DB >> 24418538

The respiratory syncytial virus (RSV) nonstructural proteins mediate RSV suppression of glucocorticoid receptor transactivation.

Jeanette I Webster Marketon1, Jacqueline Corry2, Michael N Teng3.   

Abstract

Respiratory syncytial virus (RSV)-induced bronchiolitis in infants is not responsive to glucocorticoids. We have shown that RSV infection impairs glucocorticoid receptor (GR) function. In this study, we have investigated the mechanism by which RSV impairs GR function. We have shown that RSV repression of GR-induced transactivation is not mediated through a soluble autocrine factor. Knock-down of mitochondrial antiviral signaling protein (MAVS), but not retinoic acid-inducible gene 1 (RIG-I) or myeloid differentiation primary response gene 88 (MyD88), impairs GR-mediated gene activation even in mock-infected cells. Over-expression of the RSV nonstructural protein NS1, but not NS2, impairs glucocorticoid-induced transactivation and viruses deleted in NS1 and/or NS2 are unable to repress glucocorticoid-induction of the known GR regulated gene glucocorticoid-inducible leucine zipper (GILZ). These data suggest that the RSV nonstructural proteins mediate RSV repression of GR-induced transactivation and that inhibition of the nonstructural proteins may be a viable target for therapy against RSV-related disease.
© 2013 Published by Elsevier Inc.

Entities:  

Keywords:  Gene regulation; Glucocorticoid; Nonstructural proteins; Respiratory syncytial virus

Mesh:

Substances:

Year:  2013        PMID: 24418538      PMCID: PMC3904736          DOI: 10.1016/j.virol.2013.11.014

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  70 in total

1.  Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-kappa B and NF-IL-6.

Authors:  J G Mastronarde; B He; M M Monick; N Mukaida; K Matsushima; G W Hunninghake
Journal:  J Infect Dis       Date:  1996-08       Impact factor: 5.226

2.  Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation.

Authors:  Nicholas W Lukacs; Joost J Smit; Sumanta Mukherjee; Susan B Morris; Gabriel Nunez; Dennis M Lindell
Journal:  J Immunol       Date:  2010-07-12       Impact factor: 5.422

3.  Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing.

Authors:  H Richter; P Seddon
Journal:  J Pediatr       Date:  1998-05       Impact factor: 4.406

4.  Respiratory syncytial virus represses glucocorticoid receptor-mediated gene activation.

Authors:  Adam Hinzey; Jacob Alexander; Jacqueline Corry; Kathleen M Adams; Amanda M Claggett; Zachary P Traylor; Ian C Davis; Jeanette I Webster Marketon
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

5.  The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

Authors:  Peter F Wright; Ruth A Karron; Shabir A Madhi; John J Treanor; James C King; Alice O'Shea; Mine R Ikizler; Yuwei Zhu; Peter L Collins; Clare Cutland; Valerie B Randolph; Anne M Deatly; Jill G Hackell; William C Gruber; Brian R Murphy
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

6.  Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection.

Authors:  L K Hallak; D Spillmann; P L Collins; M E Peeples
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells.

Authors:  Ping Liu; Mohammad Jamaluddin; Kui Li; Roberto P Garofalo; Antonella Casola; Allan R Brasier
Journal:  J Virol       Date:  2006-11-15       Impact factor: 5.103

8.  Glucocorticoids inhibit IRF3 phosphorylation in response to Toll-like receptor-3 and -4 by targeting TBK1 activation.

Authors:  Claire E McCoy; Susan Carpenter; Eva M Pålsson-McDermott; Linden J Gearing; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2008-03-20       Impact factor: 5.157

9.  Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases.

Authors:  L Clark Paramore; Vincent Ciuryla; Gabrielle Ciesla; Larry Liu
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

10.  Respiratory syncytial virus and TNF alpha induction of chemokine gene expression involves differential activation of Rel A and NF-kappa B1.

Authors:  Laura R Carpenter; James N Moy; Kenneth A Roebuck
Journal:  BMC Infect Dis       Date:  2002-03-28       Impact factor: 3.090

View more
  8 in total

Review 1.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

2.  Induction and Antagonism of Antiviral Responses in Respiratory Syncytial Virus-Infected Pediatric Airway Epithelium.

Authors:  Rémi Villenave; Lindsay Broadbent; Isobel Douglas; Jeremy D Lyons; Peter V Coyle; Michael N Teng; Ralph A Tripp; Liam G Heaney; Michael D Shields; Ultan F Power
Journal:  J Virol       Date:  2015-09-30       Impact factor: 5.103

Review 3.  Glucocorticoid-independent modulation of GR activity: Implications for immunotherapy.

Authors:  Janet P Hapgood; Chanel Avenant; Johnson M Moliki
Journal:  Pharmacol Ther       Date:  2016-06-08       Impact factor: 12.310

4.  Glucocorticoid Insensitivity in Virally Infected Airway Epithelial Cells Is Dependent on Transforming Growth Factor-β Activity.

Authors:  Yuxiu C Xia; Asmaa Radwan; Christine R Keenan; Shenna Y Langenbach; Meina Li; Danica Radojicic; Sarah L Londrigan; Rosa C Gualano; Alastair G Stewart
Journal:  PLoS Pathog       Date:  2017-01-03       Impact factor: 6.823

Review 5.  Glucocorticoid-Induced Leucine Zipper: Fine-Tuning of Dendritic Cells Function.

Authors:  Mathias Vétillard; Géraldine Schlecht-Louf
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

6.  Respiratory syncytial virus co-opts host mitochondrial function to favour infectious virus production.

Authors:  Marie A Bogoyevitch; David A Jans; MengJie Hu; Keith E Schulze; Reena Ghildyal; Darren C Henstridge; Jacek L Kolanowski; Elizabeth J New; Yuning Hong; Alan C Hsu; Philip M Hansbro; Peter Ab Wark
Journal:  Elife       Date:  2019-06-27       Impact factor: 8.140

Review 7.  Respiratory syncytial virus nonstructural proteins 1 and 2: Exceptional disrupters of innate immune responses.

Authors:  Koen Sedeyn; Bert Schepens; Xavier Saelens
Journal:  PLoS Pathog       Date:  2019-10-17       Impact factor: 6.823

8.  Modelling West Nile Virus and Usutu Virus Pathogenicity in Human Neural Stem Cells.

Authors:  Silvia Riccetti; Alessandro Sinigaglia; Giovanna Desole; Norbert Nowotny; Marta Trevisan; Luisa Barzon
Journal:  Viruses       Date:  2020-08-12       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.